{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:17:52Z","timestamp":1785388672023,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":291,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clinsp.2023.100301","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:30:09Z","timestamp":1699662609000},"page":"100301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2025-0349","authenticated-orcid":false,"given":"Si-hua","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-3911","authenticated-orcid":false,"given":"Xiao-li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinsp.2023.100301_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"YounossI","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinsp.2023.100301_bib0002","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinsp.2023.100301_bib0003","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.clinsp.2023.100301_bib0004","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.clinsp.2023.100301_bib0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinsp.2023.100301_bib0006","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the Framingham heart study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinsp.2023.100301_bib0007","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"Nafld and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"16","key":"10.1016\/j.clinsp.2023.100301_bib0008","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/jama.282.16.1530","article-title":"Annual deaths attributable to obesity in the United States","volume":"282","author":"Allison","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clinsp.2023.100301_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.981196","article-title":"Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clinsp.2023.100301_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.925690","article-title":"Association between SII and hepatic steatosis and liver fibrosis: a population-based study","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.clinsp.2023.100301_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/liv.14669","article-title":"Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review","volume":"41","author":"Lee","year":"2021","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.clinsp.2023.100301_bib0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4065\/74.3.243","article-title":"Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons","volume":"74","author":"Rumberger","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.clinsp.2023.100301_bib0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bmsp.12028","article-title":"Statistical mediation analysis with a multicategorical independent variable","volume":"67","author":"Hayes","year":"2014","journal-title":"Br J Math Stat Psychol"},{"issue":"9","key":"10.1016\/j.clinsp.2023.100301_bib0014","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinsp.2023.100301_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12933-021-01220-x","article-title":"Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study","volume":"20","author":"Lin","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.clinsp.2023.100301_bib0016","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/liv.14237","article-title":"Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: a prospective, community-cohort study","volume":"40","author":"Niriella","year":"2020","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.clinsp.2023.100301_bib0017","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinsp.2023.100301_bib0018","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12072-021-10167-w","article-title":"Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease","volume":"15","author":"Jin","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinsp.2023.100301_bib0019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","article-title":"Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease","volume":"299","author":"Chen","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinsp.2023.100301_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6591784","article-title":"Nonalcoholic fatty liver disease-associated liver fibrosis is linked with the severity of coronary artery disease mediated by systemic inflammation","volume":"2021","author":"Chen","year":"2021","journal-title":"Dis Markers"},{"issue":"5","key":"10.1016\/j.clinsp.2023.100301_bib0021","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jhep.2017.12.012","article-title":"Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study","volume":"68","author":"Lee","year":"2018","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.clinsp.2023.100301_bib0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study","volume":"68","author":"Chang","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinsp.2023.100301_bib0023","doi-asserted-by":"crossref","first-page":"18323","DOI":"10.1038\/s41598-020-75266-4","article-title":"Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.clinsp.2023.100301_bib0024","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jcmg.2020.01.022","article-title":"Prognostic value of coronary computed tomographic angiography in patients with nonalcoholic fatty liver disease","volume":"13","author":"Ichikawa","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.clinsp.2023.100301_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ehjci\/jev325","article-title":"Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis","volume":"17","author":"Thomsen","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.clinsp.2023.100301_bib0026","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiol.14140933","article-title":"High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial","volume":"274","author":"Puchner","year":"2015","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.clinsp.2023.100301_bib0027","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinsp.2023.100301_bib0028","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinsp.2023.100301_bib0029","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2018.01.046","article-title":"Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: results from the Multi-Ethnic Study of Atherosclerosis","volume":"259","author":"Simon","year":"2018","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.clinsp.2023.100301_bib0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.clinsp.2023.100301_bib0031","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0003319715577529","article-title":"Neutrophil to lymphocyte ratio and the extent of coronary artery disease: results from a large Cohort study","volume":"67","author":"Verdoia","year":"2016","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.clinsp.2023.100301_bib0032","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/00033197211070884","article-title":"Sex difference in the association between neutrophil to lymphocyte ratio and severity of coronary artery disease","volume":"73","author":"Pan","year":"2022","journal-title":"Angiology"},{"issue":"17","key":"10.1016\/j.clinsp.2023.100301_bib0033","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.3390\/ijms23179553","article-title":"Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence","volume":"23","author":"Dziedzic","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clinsp.2023.100301_bib0034","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/ATVBAHA.114.303564","article-title":"Neutrophils in atherosclerosis: from mice to man","volume":"35","author":"D\u00f6ring","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6116","key":"10.1016\/j.clinsp.2023.100301_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.clinsp.2023.100301_bib0036","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/geronb\/gbac051","article-title":"C-reactive protein, subjective aging, and incident cardiovascular disease: a mediation model","volume":"77","author":"Skoblow","year":"2022","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"10.1016\/j.clinsp.2023.100301_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.702138","article-title":"The effects of cardiometabolic factors on the association between serum uric acid and chronic kidney disease in chinese middle-aged and older population: a mediation analysis","volume":"12","author":"Xu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.clinsp.2023.100301_bib0038","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593223001370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593223001370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T01:37:52Z","timestamp":1725068272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593223001370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"alternative-id":["S1807593223001370"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2023.100301","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2023.100301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100301"}}